Abstract
A recent genome wide associated study in European descent population identified the association of Atrial fibrillation (AF) risk with a single nucleotide polymorphism (SNP) in SCN10A. The aim of this study was to evaluate whether SCN10A polymorphisms are associated with AF risk in the Chinese Han population. A total of 2,300 individuals of Chinese Han origin were recruited and three potentially functional SNPs were genotyped. Logistic regression models were utilized to calculate odds ratios (ORs) at a 95% confidence intervals (CIs). Logistic regression analysis in an additive genetic model revealed that one SNP in SCN10A (rs6771157) was associated with an increased risk of AF (adjusted OR = 1.20, 95% CI: 1.06 - 1.36, P = 0.003). Stratification analysis of several main AF risk factors indicated that the risk associations with rs6771157 were not statistically different among different subgroups. In summary, our study suggests the possible involvement of the SCN10A variant in AF development in Chinese Han populations. Further biological function analyses are required to confirm our finding.
Similar content being viewed by others
Introduction
Atrial fibrillation (AF), one of the most prevalent arrhythmia in clinical practice, affects 1–2% of the general population1. AF is related to a five-fold increased risk of stroke2, a three-fold increase in incidence of congestive heart failure3 and a two-fold increase in mortality rate4,5, which contribute to higher hospitalization rate in AF patients3.
The occurrence of AF is usually considered to be associated with multiple cardiovascular risk factors, such as advanced age, male, hypertension, diabetes, heart failure, and hyperthyroidism4,6,7. However, a small part of the patients with AF lack the clinical evidence of risk factors. We named this type of AF as ‘lone AF’, which account for 10–20% of the total AF8. Several studies have demonstrated that AF, especially lone AF, have a predisposing genetic component9,10,11,12. Over the past decade, multiple genetic variants, including common and rare genetic variants, had been reported to be associated with susceptibility to AF13,14,15. In 2010, a genome-wide association study (GWAS) by Pfeufer et al. detected an intronic SNP (rs6800541) in SCN10A that is independently associated with PR-interval and AF risk (P = 9.7 × 10−82, P = 0.5 × 10−4, respectively)16. A meta-analysis of 14 GWASs discovered that another intronic SNP (rs6801957) in SCN10A may be a major risk marker for prolonged QRS duration in individuals of European descent17. Further functional analyses have confirmed that SCN10A was expressed in human ventricular conduction system and the loss of SCN10A had an apparent impact on both PR interval and QRS duration in mouse models17,18. These facts indicate that SCN10A may be involved in the development of AF. In this study, we employed candidate gene approach to identify potentially functional AF susceptibility SNPs in SCN10A in Chinese Han populations.
Results
Characteristics of the Study Population
We recruited 2,300 individuals of Chinese Han origin in this study totally, including 1,150 AF cases and 1,150 AF-free controls. The clinical characteristics between cases and controls are summarized in Table 1. In brief, the variants of gender and age in two groups were comparable (P > 0.05). Compared with the non-AF subjects, AF patients were more likely to have the percentages of hypertension, diabetes and coronary artery disease (CAD) (45.1% vs. 20.8%, P < 0.001 for hypertension, 10.5% vs. 7.5%, P = 0.011 for diabetes and 10.3% vs. 0%, P < 0.001 for CAD, respectively).
Associations between SCN10A variants and AF risk
The genotype distributions of the three SNPs and their associations with AF risk are shown in Table 2. The genotype frequencies of these SNPs were all observed in agreement with Hardy–Weinberg equilibrium in the control group. The logistic regression analyses revealed that the rs6771157 C allele was significantly associated with the increased risk of AF in an additive model (adjusted OR = 1.20, 95% CI: 1.06–1.36, P = 0.003). We further calculated P values for false discovery rate (P-FDR) to perform multiple comparisons, which found that rs6771157 still remained association with the risk of AF (P-FDR = 0.010). There was no obvious evidence of significant association between the other two SNPs and AF risk.
Stratification Analysis
We assessed the effect size of rs6771157 with AF by stratification analyses based on the main AF risk factors such as age, gender, hypertension, diabetes. As shown in Table 3, no significant difference for the association of rs6771157 with AF risk between subgroups was detected (P > 0.05 for heterogeneity test).
Discussion
This case-control study investigated the relationship between the common genetic variants of SCN10A and their potential function in the risk of AF in the Chinese Han population. Only SNP rs6771157 was identified to be significantly associated with Chinese Han AF risk.
SCN10A encodes the voltage-gated sodium channel, Nav1.8 channels. The protein product of SCN10A is predominant tetrodotoxin-resistant sodium channel in primary sensory neurons19,20. Although the exact role of Nav1.8 in cardiac electrophysiology remains currently unclear21, SCN10A is expressed both in intracardiac neurons and human cardiomyocytes22,23. Further, blockade of Nav.18 channels suppresses the impact of vagus nerve stimulation (VNS) on both cardiac conduction and AF inducibility23,24,25. Thus, SCN10A plays an important role in cardiac electrophysiology and modulating susceptibility to arrhythmias24.
In a previous GWAS. A tag SNP (rs6800541) in SCN10A has been found to have a strong association with PR-interval duration and AF16. Most recently, a function study by Jabbari et al. revealed two common nonsynonymous variants in SCN10A (rs6795970, rs12632942) result in a gain-of-function of Nav1.8 channel21. In the present study, we found an association between another common variant rs6771157 and AF risk in Chinese Han populations. We analyzed the linkage disequilibrium of SNP rs6771157 with the two significant SNPs via haploview software, which showed r2 = 0.1 and 0.171 for rs6800541 and rs6801957 respectively (Fig. 1). Thus, the rs6771157, a synonymous variant located in the 19 exon of SCN10A. is a signal different from the two SNPs reported in European individuals. It was predicted as a functional SNP in an ESE (exon splicing enhancer) by the online tool SNPinfo (http://snpinfo.niehs.nih.gov/index.html), which may be responsible for aberrant splicing of pre-mRNA of SCN10A by binding to the SR proteins of splicing activators26. A possible explanation is that rs6771157 causes the exon skipping by activating the creation of the ESE.
Several limitations of the present study need to be considered. Firstly, the sample size is relatively small compared to GWAS, which may predispose to the failure to detect effects of another two potential functional SNPs in our study. Secondly, echocardiography results and N-terminal of the prohormone brain natriuretic peptide (NT-proBNP) levels were not available for all the individuals to evaluate cardiac functions, which may have resulted in information bias. We did not evaluate cardiac functions by left ventricular ejection fraction (LVEF) and NT-proBNP. Furthermore, we selected the potential functional SNP by using on-line tools, which may result in positive or negative errors. Thus, further replication in larger sample sets and mechanism researches are required to confirm our findings.
In conclusion, the current investigation confirmed that one functional common variation (rs6771157) in SCN10A was significantly associated with the risk of AF in a Chinese Han population. However, the role of this variant in the AF susceptibility is warranted to be further evaluated by function studies.
Methods
Study population
This study was approved by Ethical Committee Review Board of Nanjing Medical University, China. The written informed consents were obtained from all the participants enrolled in the study. The experimental protocol was carried out in accordance with the approved guidelines.
The AF cases were recruited from Department of Cardiology, the First Affiliated Hospital of Nanjing Medical University from June 2010 to December 2014. We included AF patients according to their routine 12-lead electrocardiography (ECG), or holter ECG recordings which were characterized with irregular R-R intervals, absence of distinct repeating P waves, and irregular atrial activity27. We classified AF as paroxysmal AF (terminates spontaneously or with intervention within 7 days of onset), persistent AF (episodes that sustain beyond 7 days). We defined “Lone AF” as young AF individuals (<60 years) without clinical or echocardiographic evidence of cardiopulmonary disease3. The controls were recruited from other departments of the First Affiliated Hospital of Nanjing Medical University, and they were all confirmed to be free of AF based on medical files or ECG at the time of enrollment.
The general and clinical information of all participants was collected from medical recording files in the hospital system. We excluded patients with hyperthyroidism, severe cardiac dysfunction (NYHA Class IV), valvular heart disease and advanced age (beyond 90 years) in AF group. All individuals were Chinese Han origin.
SNP selection
We first used public HapMap SNP database (phase II+III Feb 09, on NCBI B36 assembly, dbSNP b126) to search SNPs that localized within the gene region of SCN10A (including 10 kb upstream of the gene), with MAF (Minor Allele Frequency) ≥ 0.05 in Chinese Han population. Then, a web-based analysis tool was used to predict the function of these SNPs (http://snpinfo.niehs.nih.gov/snpinfo/snpfunc.htm). After function prediction analysis, a total of six potentially functional SNPs were selected. We conducted linkage disequilibrium (LD) analysis to exclude SNPs with strong LD (r2 ≥ 0.8), then three (rs9827941, rs7630989, and rs6771157) functional SNPs were selected for further genotyping.
SNP genotyping
Peripheral venous blood samples were drawn from study participants. Genomic DNA was extracted from EDTA-preserved whole blood using a standard phenol-chloroform method28. The genotyping was conducted using the method of the improved multiple ligase detection reaction (iMLDR) with the technical assistance from Shanghai Genesky Bio-Tech Genetic Core Lab. All SNPs were genotyped successfully with call rates at least of 99.3%.
Statistical analysis
The comparisons of clinical characteristic differences between cases and controls were identified using Student’s t test for continuous variables and the χ2 test for categorical variables. The deviation of genotype distribution from Hardy-Weinberg equilibrium was tested by χ2 test in the control group. ORs and 95% CIs were calculated to assess the relationships between the SNPs and the risk of AF using logistic regression. The heterogeneity of associations among subgroups was evaluated using the χ2-based Q-test. All statistical analyses were performed with STATA 12.0 software (Stata Corp., College Station, TX, USA). P < 0.05 was the criterion of statistical significance and all statistical tests were two-tailed. LD analysis was applied by using Haploview 4.2 software.
Additional Information
How to cite this article: Fang, Z. et al. The rs6771157 C/G polymorphism in SCN10A is associated with the risk of atrial fibrillation in a Chinese Han population. Sci. Rep. 6, 35212; doi: 10.1038/srep35212 (2016).
References
Camm, A. J. et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace: European pacing, arrhythmias, and cardiac electrophysiology: journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 12, 1360–1420, doi: 10.1093/europace/euq350 (2010).
Wolf, P. A., Abbott, R. D. & Kannel, W. B. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke; a journal of cerebral circulation 22, 983–988 (1991).
Camm, A. J. et al. Focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation–developed with the special contribution of the European Heart Rhythm Association. Europace: European pacing, arrhythmias, and cardiac electrophysiology: journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 14, 1385–1413, doi: 10.1093/europace/eus305 (2012).
Kannel, W. B., Abbott, R. D., Savage, D. D. & McNamara, P. M. Epidemiologic features of chronic atrial fibrillation: the Framingham study. The New England journal of medicine 306, 1018–1022, doi: 10.1056/nejm198204293061703 (1982).
Benjamin, E. J. et al. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98, 946–952 (1998).
Benjamin, E. J. et al. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. Jama 271, 840–844 (1994).
Psaty, B. M. et al. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 96, 2455–2461 (1997).
Fuster, V. et al. ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Journal of the American College of Cardiology 57, e101–198, doi: 10.1016/j.jacc.2010.09.013 (2011).
Darbar, D. et al. Familial atrial fibrillation is a genetically heterogeneous disorder. Journal of the American College of Cardiology 41, 2185–2192 (2003).
Ellinor, P. T., Yoerger, D. M., Ruskin, J. N. & MacRae, C. A. Familial aggregation in lone atrial fibrillation. Human genetics 118, 179–184, doi: 10.1007/s00439-005-0034-8 (2005).
Arnar, D. O. et al. Familial aggregation of atrial fibrillation in Iceland. Eur Heart J 27, 708–712, doi: 10.1093/eurheartj/ehi727 (2006).
Christophersen, I. E. et al. Familial aggregation of atrial fibrillation: a study in Danish twins. Circulation. Arrhythmia and electrophysiology 2, 378–383, doi: 10.1161/circep.108.786665 (2009).
Lubitz, S. A., Yi, B. A. & Ellinor, P. T. Genetics of atrial fibrillation. Heart failure clinics 6, 239–247, doi: 10.1016/j.hfc.2009.12.004 (2010).
Sinner, M. F., Ellinor, P. T., Meitinger, T., Benjamin, E. J. & Kaab, S. Genome-wide association studies of atrial fibrillation: past, present, and future. Cardiovascular research 89, 701–709, doi: 10.1093/cvr/cvr001 (2011).
Olesen, M. S., Nielsen, M. W., Haunso, S. & Svendsen, J. H. Atrial fibrillation: the role of common and rare genetic variants. European journal of human genetics: EJHG 22, 297–306, doi: 10.1038/ejhg.2013.139 (2014).
Pfeufer, A. et al. Genome-wide association study of PR interval. Nature genetics 42, 153–159, doi: 10.1038/ng.517 (2010).
Sotoodehnia, N. et al. Common variants in 22 loci are associated with QRS duration and cardiac ventricular conduction. Nature genetics 42, 1068–1076, doi: 10.1038/ng.716 (2010).
Chambers, J. C. et al. Genetic variation in SCN10A influences cardiac conduction. Nature genetics 42, 149–152, doi: 10.1038/ng.516 (2010).
Fukuoka, T. et al. Comparative study of the distribution of the alpha-subunits of voltage-gated sodium channels in normal and axotomized rat dorsal root ganglion neurons. The Journal of comparative neurology 510, 188–206, doi: 10.1002/cne.21786 (2008).
Renganathan, M., Cummins, T. R. & Waxman, S. G. Contribution of Na(v)1.8 sodium channels to action potential electrogenesis in DRG neurons. Journal of neurophysiology 86, 629–640 (2001).
Jabbari, J. et al. Common and rare variants in SCN10A modulate the risk of atrial fibrillation. Circulation. Cardiovascular genetics 8, 64–73, doi: 10.1161/hcg.0000000000000022 (2015).
Facer, P. et al. Localisation of SCN10A gene product Na(v)1.8 and novel pain-related ion channels in human heart. Int Heart J 52, 146–152 (2011).
Verkerk, A. O. et al. Functional Nav1.8 channels in intracardiac neurons: the link between SCN10A and cardiac electrophysiology. Circulation research 111, 333–343, doi: 10.1161/circresaha.112.274035 (2012).
Savio-Galimberti, E. et al. SCN10A/Nav1.8 modulation of peak and late sodium currents in patients with early onset atrial fibrillation. Cardiovascular research 104, 355–363, doi: 10.1093/cvr/cvu170 (2014).
Qi, B. et al. Nav1.8 channels in ganglionated plexi modulate atrial fibrillation inducibility. Cardiovascular research 102, 480–486, doi: 10.1093/cvr/cvu005 (2014).
Lee, Y. & Rio, D. C. Mechanisms and Regulation of Alternative Pre-mRNA Splicing. Annual review of biochemistry 84, 291–323, doi: 10.1146/annurev-biochem-060614-034316 (2015).
January, C. T. et al. AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Journal of the American College of Cardiology 64, e1–76, doi: 10.1016/j.jacc.2014.03.022 (2014).
Albarino, C. G. & Romanowski, V. Phenol extraction revisited: a rapid method for the isolation and preservation of human genomic DNA from whole blood. Molecular and cellular probes 8, 423–427, doi: 10.1006/mcpr.1994.1060 (1994).
Acknowledgements
The authors thank Shanghai Genesky Bio-Tech Genetic Core Lab for assistance in genotyping techniques.
Author information
Authors and Affiliations
Contributions
Study concept and design: F.Z. and Z.F. Acquisition of data: Z.F., Y.J., Y.L., L.Z. and Y.X. Analysis and interpretation of data: Y.W. and Y.L. Drafting the manuscript: Z.F., Y.W., Y.L., M.B.T. and S.H. Critical revision Statistical analysis: Y.J., Y.W. and F.Z.
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
About this article
Cite this article
Fang, Z., Jiang, Y., Wang, Y. et al. The rs6771157 C/G polymorphism in SCN10A is associated with the risk of atrial fibrillation in a Chinese Han population. Sci Rep 6, 35212 (2016). https://doi.org/10.1038/srep35212
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/srep35212
- Springer Nature Limited